Envoy Medical Warrant
COCHW
54 hedge funds and large institutions have $1.4M invested in Envoy Medical Warrant in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
54% more capital invested
Capital invested by funds: $914K → $1.4M (+$490K)
40.33% more ownership
Funds ownership: 0% → 40.33% (+40%)
20% more funds holding
Funds holding: 45 → 54 (+9)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$14.4K |
| 2 |
Man Group
London,
United Kingdom
|
+$12.5K |
| 3 |
Walleye Capital
New York
|
+$9.53K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.02K |
| 5 |
AC
Antara Capital
New York
|
+$5.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$24.1K |
| 2 |
PI
PineBridge Investments
New York
|
-$14.6K |
| 3 |
VI
Vestcor Inc
Fredericton,
New Brunswick, Canada
|
-$14K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$13.7K |
| 5 |
SG
StoneX Group
New York
|
-$2.23K |
COCHW Hedge Fund Activity: Q4 2023 in Review
54 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q4 2023, worth a combined $1.4M — up 54% from $914K a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new COCHW positions and 8 closed out — a net gain of 11 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Diametric Capital, opening a new position worth an estimated $14.4K. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $24.1K sold.
- 54 institutional investors held Envoy Medical Warrant (COCHW) as of Q4 2023, up from 45 in Q3 2023.
- Funds reported $1.4M of Envoy Medical Warrant stock for Q4 2023, up 54% quarter-over-quarter.
- 19 funds opened new Envoy Medical Warrant positions in Q4 2023 and 8 closed out, a net change of +11 holders.
- The largest Envoy Medical Warrant buyer in Q4 2023 was Diametric Capital, an estimated $14.4K added.
- The largest Envoy Medical Warrant seller in Q4 2023 was BNP Paribas Financial Markets, an estimated $24.1K sold.
Based on aggregated 13F filings for Q4 2023.